BioMedIQX — Proprietary Sublingual Spray Technology
Our team of scientists, medical and business professionals have successfully reimagined an ideal absorption methodology for the intake of nutritional supplements and medicine.
About
Mission Statement
Our innovative Molecular Spray System® technology will positively impact the health and wellbeing of over 1 billion people.
Vision Statement
We generate a global awareness with consumer demand and adoption of our spray solution for the delivery of essential nutrients and medications. The 
branding is a recognized symbol of quality health products and known as The Intelligent Prescription™️
Founder’s Message
My professional experience has fortunately enabled me to align with an amazing team of scientific, healthcare, and business leaders. Our combined efforts have developed a disruptive medical innovation by providing an ideal alternative to taking pills for many aspects of a person’s health maintenance regimen. Our spray technology represents 13-years of manufacturing expertise that provides highly effective, safe, precision dosing of nutritional and medicinal formulations. Our team is poised to improve the wellbeing of all those who use our products as we continue to address the unmet needs of millions of people who struggle with or simply dislike having to consume pills for their healthcare needs. My team and I share an unwavering commitment to addressing our customers’ needs through our mission to dramatically improve human health.
– Clay Kahler, Founder
Top Product Lines:
Sprays: Our flagship line of products includes supplements and nutraceuticals that are currently available along with OTC and prescription medications that are in varying stages of market readiness. Our supplement and nutraceutical product line includes over 20 unique product formulations, which include our clinically studied sleep formula along with Multivitamin, D3, D3 K2, B12, C-Zinc, Folate, E-Selenium, Folate, Ubiquinol, Trace Minerals, L-Theanine, Magnesium and others.
: Our specialty supplements, nutraceuticals, and medications specifically formulated for the Pediatric, Geriatric, and Bariatric populations.
: Our forward-looking vision focused on the emerging market for psychedelic medications, which we will be uniquely positioned to address once the legal framework allows us to enter the market.
Explore Our Product Offerings
Each of the following three product lines have unique, market-ready products.
SPRAYS
Sprays are at the forefront of innovation by creating highly effective oral spray delivery of dietary/nutritional supplementation and medicines. Our products are crafted with precision and care, and are designed to provide optimal dosage, superior absorption and the convenience of not having to take more pills. Our goal is to ensure your body gets the support it needs for overall health and wellness.
- Enhanced Absorption
- Convenience and Ease of Use
- Tailored Formulations
- Pure Ingredients
- Rapid Effect
- No More Pill Fatigue
- Optimal Dosage
is our Pediatric, Geriatric, and Bariatric focused line of specialty nutritional products formulated to address the unique needs of the targeted customer. The market size for our products is immense. Current data indicates the following:
- Pediatric: Children’s supplement revenues were estimated at USD 3.99 Billion in 2023 and are anticipated to grow at a CAGR of 6.7% from 2023 to 2032, according to a recently published Custom Market Insights report. By the end of 2032, the market is expected to reach a valuation of USD 6.77 Billion Custom Market Insights
- Geriatric: Global elderly nutrition market size was valued at USD 1.70 billion in 2022 and is expected to witness a CAGR of 6.80% over the forecast period (2022 – 2030) rendering a projected value in 2030 of USD 2.88 billion Data Bridge Market Research
- Bariatric: The Bariatric Surgery Market Size was valued at USD 1.8 billion in 2022 and is projected to grow from USD 1.9 Billion in 2023 to USD 3.82 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2023 - 2032) Market Research Future
is one of our key offerings, it promises to transform the generic medicine landscape with innovative delivery systems. It is focused on delivering affordable Solutions without a compromise.
- Enhanced Bioavailability: Utilizing spray technology, GenerIQx improves the absorption and effectiveness of medications.
- Patient-Centric Formulations: Designed with patient convenience and compliance in mind, making treatments easier and more efficient.
- Sustainable Practices: Emphasizing eco-friendly production and packaging to reduce environmental impact.
The U.S. generic drugs market was valued at approximately $133.44 billion in 2023 and is expected to grow significantly to reach about $189.77 billion by 2033, reflecting a compound annual growth rate (CAGR) of 3.5% from 2024 to 2033 (precedenceresearch).
Our line of products address the growing consumer interest in psychedelic assisted therapy. Significant studies and clinical trials are being conducted around the globe in an effort to validate safety and effectiveness of molecules including MDMA, Psilocybin, Ibogaine and other entheogens. Each of these substances is seeking a pathway to regulatory clearance. Upon successful rescheduling, the market potential will be significant. Current therapeutic use of Ketamine has seen a dramatic increase in the past few years. Our founding team has extensive experience from owning and operating a ketamine clinic for the past three-years. The knowledge we gained has led us to develop products that are becoming positioned to go to market. We will be announcing our strategic plans relating to this exciting endeavor in Q2 2024.
Data supporting the growth of psychedelics includes:
- The psychedelic drug market was valued at USD 5 billion in 2023 and is projected to reach a valuation of USD 11.82 billion by 2029, registering a CAGR of 13.49% over the forecast duration of 2022-2026 PR News Wire
Our Lab, Technology & Benefits
Our Lab
Proprietary Chemistry
Advantages Over Traditional Methods
- Safety: Minimizes the risk of gastrointestinal irritation and other side effects associated with oral tablets and invasive methods.
- Convenience: Our sprays offer an easy-to-use alternative to swallowing pills or undergoing injections, ideal for on-the-go lifestyles.
- Enhanced Bioavailability: Direct absorption into the bloodstream leads to better utilization of active ingredients, offering quicker and more potent effects.
Sustainability
Committed to both health and the planet, our sprays are vegan, gluten-free, and non-GMO. We prioritize eco-friendly practices and sustainable sourcing, ensuring our products are as good for the earth as they are for you.
Market Opportunity for
- The U.S. dietary supplements market size was valued at USD 42.85 billion in 2023 and is expected to reach USD 71.16 billion by 2032, growing at a CAGR of 5.80% from 2023 to 2032. Precedence Research
- The US generic drugs market size was evaluated at USD 133.44 billion in 2023 and is projected to hit around USD 189.77 billion by 2033, registering a CAGR of 3.5% from 2024 to 2033. Precedence Research
- The psychedelic drugs market is projected to grow from approximately USD 5 billion in 2023 to USD 11.82 billion by 2029, showcasing significant growth potential.
Competitive Advantage:
is a positive disruptive force with its technology and innovative delivery platform. Our core focus is to address the growing needs of both nutritional supplements and OTC/Prescription medications, along with the burgeoning field of psychedelic drugs,. The company’s proprietary technology offers superb bioavailability, safe and measurable dosing, and added convenience over traditional delivery methods. With a strong foundation in proprietary chemistry and oral efficacy, is poised to capture market share. We leverage our expertise in the biotech space and deploy a strategic focus on direct-to-consumer and direct-to-business pharmaceutical sales. Here a few key points:
- Our team is comprised of scientists, medical doctors, wellness and business leaders.
- Innovative sublingual spray delivery of Nutritional Supplements and Medicines developed and manufactured by industry leaders.
- We have over 13-years of extensive research and product development combined within our FDA registered and cGMP certified manufacturing facility.
Send Us A Message
"*" indicates required fields
NOTE: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease